SCIEGEN PHARMS INC FDA Approval ANDA 212077

ANDA 212077

SCIEGEN PHARMS INC

FDA Drug Application

Application #212077

Documents

Letter2021-01-08

Application Sponsors

ANDA 212077SCIEGEN PHARMS INC

Marketing Status

None (Tentative Approval)001

Application Products

001CAPSULE;ORAL267MG0PIRFENIDONEPIRFENIDONE

FDA Submissions

UNKNOWN; ORIG1TA2020-11-16STANDARD

Submissions Property Types

ORIG1Null31

TE Codes

001PrescriptionAB

CDER Filings

SCIEGEN PHARMS INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 212077
            [companyName] => SCIEGEN PHARMS INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"PIRFENIDONE","activeIngredients":"PIRFENIDONE","strength":"UNKNOWN","dosageForm":"UNKNOWN","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"11\/16\/2020","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-11-16
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.